CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-08 | Evans Carl Anthony Director | Grant or award · Option to purchase common stock | +17,500 | 129,594 | ||
| 2024-04-08 | Evans Carl Anthony Director | Grant or award · Restricted Stock Units | +17,500 | 147,094 | ||
| 2024-04-08 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock | +40,000 | 201.57 | ||
| 2024-04-08 | Downs Christopher Chief Financial Officer | Grant or award · Restricted Stock Units | +40,000 | 241.57 | ||
| 2024-04-08 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +17,500 | 35,574 | ||
| 2024-04-08 | Cockroft Bettina M. Director | Grant or award · Restricted Stock Units | +17,500 | 53,074 | ||
| 2024-04-08 | Climaco John M Chief Executive Officer | Grant or award · Option to purchase common stock | +83,000 | 476,533 | ||
| 2024-04-08 | Climaco John M Chief Executive Officer | Grant or award · Restricted Stock Units | +83,000 | 559,533 | ||
| 2024-04-08 | Charles Faith L. Director | Grant or award · Option to purchase common stock | +17,500 | 47,315 | ||
| 2024-04-08 | Charles Faith L. Director | Grant or award · Restricted Stock Units | +17,500 | 64,815 | ||
| 2024-02-01 | Mahery Amy Director | Grant or award · Option to purchase common stock | +12,420 | 12,420 | ||
| 2024-02-01 | Gumulka Jerzy Director | Purchase | +33,333 | $0.30 | $10K | 43,006 |
| 2024-02-01 | Gumulka Jerzy Director | Grant or award · Series A Warrant to purchase common stock | +33,333 | 78,761 | ||
| 2024-02-01 | Gumulka Jerzy Director | Grant or award · Series B Warrant to purchase common stock | +33,333 | 112,094 | ||
| 2024-02-01 | Evans Carl Anthony Director | Purchase | +33,333 | $0.30 | $10K | 33,458 |
| 2024-02-01 | Evans Carl Anthony Director | Grant or award · Series A Warrant to purchase common stock | +33,333 | 78,761 | ||
| 2024-02-01 | Evans Carl Anthony Director | Grant or award · Series B Warrant to purchase common stock | +33,333 | 112,094 | ||
| 2024-02-01 | Downs Christopher Chief Financial Officer | Purchase | +66,666 | $0.30 | $20K | 103,438 |
| 2024-02-01 | Downs Christopher Chief Financial Officer | Grant or award · Series A Warrant to purchase common stock | +66,666 | 94,906 | ||
| 2024-02-01 | Downs Christopher Chief Financial Officer | Grant or award · Series B Warrant to purchase common stock | +66,666 | 161,572 |
Page 2 of 6 · 110 trades